Country Profile

Spain

Spain is a significant market for Indian pharmaceutical exports — $267M in FY 2025–26, with 2.1× growth over the past decade. Medicine Ingredients accounts for 45% of shipments. The compound annual growth rate since FY2015 stands at 7.1%.

🇪🇸 $267M · 2.1× growth since FY2015 · 7.1% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$267M
Exports FY2025–26 DGCIS
2.1×
Growth FY2015→2026
7.1%
CAGR FY2015→2026
45%
Medicine Ingredients Share
4
Product Categories Supplied
Spain is a significant market for Indian pharmaceutical exports — $267M in FY 2025–26, with 2.1× growth over the past decade. Medicine Ingredients accounts for 45% of shipments. The compound annual growth rate since FY2015 stands at 7.1%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $119M (44.6%) Medicines $106M (39.7%) Surgical & Hospital Supplies $31.1M (11.7%) Traditional & Herbal $10.7M (4.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Spain in the RBI overseas direct investment dataset (2011–2026).